MaxCyte (MXCT) 2025 Earnings Outlook for Investors
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesMaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
AscendEX ceased normal operations on July 1 as MiCA rules tightened, with withdrawal requests slowed or blocked. Zach...
A specialized REIT with cannabis-related tenants moved higher in today’s session. This article breaks down the factor...
A senior U.S. senator warns that college grad unemployment will surge as AI reshapes entry-level work, potentially up...
AMD CEO Lisa Su addressed MIT Class of 2026 graduates with a call to apply AI with purpose and judgment, signaling ho...
With July 16 earnings just days away, Taiwan Semiconductor is shaping up as a high-conviction play thanks to expandin...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
The broadcom sell-off: this huge moment is more than a single stock move. It underscores how AI optimism meets market...
High-profile legal battles hit more than headlines—they hit your wallet. Discover how the stefon diggs legal fight hi...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...